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In the treatment of neurovascular disturbances of the cli-
macteric, one of the most used therapeutic agents is estrogen,
the ovarian follicular hormone. Its effectiveness in the majority
of cases is now well established. Little is known, however,
concerning the mechanism by which relief from hot flushes is
afforded. It is known that subsidence of symptoms coincides
with the disappearance of a gonadotropic substance (arising in
the pituitary?) in the urine, but the hypothesis that relief from
the vascular disturbance of the menopause is the result of sup-
pression of pituitary-overactivity leaves unanswered the ques-
tion of how suppression of the heightened vasomotor irritability
takes place.
The experiments described below were made, therefore, to
ascertain what demonstrable peripheral vascular effects, if any,
estrogen has. Obseryations have been made in the ear of the
rabbit, and on the human finger both in men and in women in,
or near, the menopause. The results of the experiments on the
ear of the rabbit have been published in detail elsewhere, (Rey-
nolds and Foster, 1940) so these will be briefly siimmrized here,
along with data obtained in the human male (cf. Reynolds and
Foster, 1939), Study of the dermovascular action of estrogen
in menopausal women is still in progress, so the following account
of these experiments should be considered as a preliminary report.
* Readbefore the 3rd Annual Meeting of the Society for Investigative Derma-
tology, New York, June 11, 1940.
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I. DERMOVASCULAR ACTION OF ESTROGEN IN THE EAR OF THE
RABBIT'
In this work, the effect of estrogenic hormone on the blood
vessels of the skin was observed in the transiluminated ear of
the rabbit. Ovariectomized animals were used in order to elimi-
nate a source of estrogen in the organism. At the time of an
experiment, the rabbit was given a hypnotic dose of a barbiturate
anesthesia (Dial, Ciba), and then so placed that it was lying
comfortably on a padded board, protected from drafts. In
order to be certain that the condition of the blood vessels was
not modffied primarily by changes in temperature, records were
kept of the rectal temperature, ear temperature (by means of
a sensitive thermocouple) and of room temperature.
As a result of a number of preliminary experiments, we were
able to confirm the extensive observations of Grant (1935—36) on
the ear of the rabbit, both as to the types of blood vessels found
in these tissues and the effect of changes in temperature upon
them. This investigator determined that there are three prin-
cipal types of blood vessels to be seen: A) the main vessels (mean-
ing the central artery, its main branches, and chief veins); B)
the small vessels (meaning the network of small arteries and
veins that cover the blade of the ear and are visible to the naked
eye); C) the minute vessels (including the arterioles, venules,
arteriovenous-anastomosis and the capillaries which are indis-
tinguishable to the naked eye but give rise to the ground color of
the ear). The state of the minute vessels is readily gauged by
this ground color. There are two especially significant facts
concerning the last, or C group of vessels above. First, it was
observed by Grant that denervation of the ear does not affect
their responses to chemical, mechanical, or thermal stimuli,
and second, the C group of vessels resemble qualitatively the
blood vessels of the human skin to such stimuli. The blood ves-
sels of the rabbit ear, however, are more liable to changes in
temperature than are those of human skin, apparently because
Supported by grants from the Committee on Research in Endocrinology,
National Research Council, the Committee on Scientific Research, A. M. A.,
and the Josiah Macy, Jr. Foundation.
DEBMOVASCULAR ACTION OF ESTROGEN 9
the ears of the rabbit constitute a primary route for heat-loss,
while in the human, heat-loss takes place from a relatively much
larger surface.
The effect of estrogen, it was repeatedly observed, is limited to
the smallest vessels lying beyond the arterioles, namely, the
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14 5
FIG. 1. Diagram of blood vessels in a field of the ear of an ovariectomized
rabbit. A, before injection of estradiol; B, fourteen minutes later. (Reprinted
from the Jour. Pharmacol. Exp. Therap., 68: 179, 1940.)
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FIG. 2. Curve of light-extinction of transmitted light in the ear of a rabbit
before and following injection of estrogen. The intensity of transmitted light
is diminished as vasodilatation takes place. A Lange photoelectric cell was
employed.
capifiaries and venules and possibly the arteriovenous anas-
tomoses. It is characterized by dilatation of the vessels within
the first three to twenty minutes. This is seen by opening of
an extensive network of vessels which may be detected in only
fragmentary bits during the preinjection period. In addition
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numerous capillary loops open, also. Red blood cells frequently
may be seen trailing by. The dilatation persists throughout
the period of observation, as shown in figures 1 and 2.
Several considerations show that only the smallest vessels
in the ear are affected. First, those which respond are demon-
strable in the C group, as noted above; second, the measurements
of skin temperature show that at moderate or low room tem-
peratures (ca. 18°C. to 24°C.), the vasodilatation takes place
either with no change in ear temperature or with a fall in skin
temperature (see fig. 3). Third, the ground color of the ear
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FIG. 3. Curves of skin temperature, rectal temperature and room temperature
in an ovariectomized rabbit before and following injection of estrogen. The
decrease in skin temperature occurred as a result of decreased blood flow in the
ear when the smallest blood vessels dilated under the influence of estrogen.
becomes pinkish—an evidence of moderate dilatation of the
smallest capifiaries and venules, as Grant has established.
Such experiments performed under suitable conditions show,
therefore, that while estrogen causes dilatation of the minute
vessels (capillaries and venules), the rate of blood flow through
the ear does not increase materially. This varies, rather, with
the requirements for heat-loss which vasodilatation of the smallest
vessels imposes in the regulation of normal body temperature
under different experimental conditions. Nevertheless, it is
clear on physiological grounds that with an enlarged capillary
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bed in the ears, the possibility for increased heat-loss, with less
arteriolar (vasomotor) adjustment is readily possible.
II. DERMOVASCULAR ACTION OF ESTROGEN IN THE HUMAN
Im the male.1 In twenty-nine experiments on twenty males,
increase in finger-volume was demonstrated with a plethysmo-
graph nineteen times in twelve of the subjects. Six failed to
respond to the hormone for unknown reasons, and two responded
to the injection of corn oil alone as well as to the hormone. The
ast two are not included in the group of subjects considered to
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Fxo. 4. Non-effect of cornoil on finger volume (in the human male, recorded
plethysmographically). (Reprintedfrom the Jour. Clin. Invest., 18: 651, 1939.)
be specifically susceptible to the dermovascular action of estrogen.
In the hormone-responsive group, none responded to corn oil
(see fig. 4), although all injections, hormone and corn oil, were
made as "unknowns" to the subjects. The hormone (usually
10,000 rat units) was injected intramuscularly into the free arm
of the subject who was comfortably seated.
A typical response is shown in figure 5. Within three to
fifteen minutes, the volume of the finger begins to increase, oc-
casionally after a transient decrease (i.e. vasoconstriction re-
sulting from nervousness at the time of injection). The finger-
volume becomes steadily larger for at least half an hour, although
more often the period of change lasts forty-five minutes to an
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hour. The finger remains large for a period in excess of the
maximum time of observation (two hours). During the period
of vasodilatation, there is no perceptible rise in nail bed tem-
perature, or in the temperature of the plethysmograph. This
means, therefore, that the volume-change is effected without a
significant alteration in the rate of blood flow. It therefore
follows that vasodilatation occurs beyond the smallest arterioles.
The magnitude of the change in finger-volume, may be men-
tioned in passing. The smallest percentage change observed
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Fm. 5. Effect of estrogen, administered intramuscularly, on finger volume in
the human male. (Reprinted from same article as fig. 4.)
was 0.8%, the largest 8.3%, and the mean, 4.6%. In order to
appreciate the extent of this volume-change, it should be pointed
out that the fleshy part of four embalmed fingers was 56%.
Since the above noted increase in finger-volume was limited to
such parts of the finger, the actual volume-change was about
double the values just quoted.
In women in menopause.2 In this work, twenty-five women
have been studied. Twelve were in surgical menopause, thirteen
in natural menopause. All were carefully selected from a large
2 Supported by grants from the Committee on Research in Endocrinology,
National Research Council, and the Josiah Macy, Jr. Foundation.
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group of women attending the outpatient clinic at the Green-
point City Hospital. The necessary condition for selection in
this work was that the patient had to have as a primary com-
plaint frequent and intense hot flushes of menopausal origin of
sufficient severity that she sought medical relief. In addition,
an attempt was made to select patients who showed no other
important clinical findings. Even so, some presented various
kinds of nervous instability (e.g., involutional melancholia, para-
noid dementia precox, and nervous tension resulting most often
from poor family conditions). As the work developed, several
had other disabilities which rendered them unsuitable for con-
tinued observation. These included cases of hypertension,
rheumatism, proliferative hypertrophic arthritis, malnutrition
and endocrine obesity. The patients attended the clinic for
varying periods of time—some (eight) for several weeks or a
month until it was evident that some other type of treatment
was indicated, and others (seventeen) are continuing for periods
now ranging from three to seven months. Two of these are
sufficiently relieved that they now come in at long and irregular
intervals. All the cases studied, however, have yielded some
useful information especially with regard to the role of psychic
factors involved in the menopausal flush. In this report, empha-
sis will be laid on the more objective vascular data that have been
obtained.
Character of the response. Two types of dermovascular re-
sponse have been observed in these patients. One, like that
seen in the male, consists of a slow rise in the curve to a sustained
plateau (see fig. 6). The amplitude of this response varies with
conditions that are not fully known at the present time. One
appears to be the length of time the patient has been under
treatment, another, the mental state of the subject. Careful
review of the data now obtained show it not to be associated
This work is made possible through permission granted by Dr. Thurston
Scott Welton, Chief of Service in the clinic in which we are working. Associated
with the writer in this is Dr. Sanford Kaminester, of the Department of Obstetrics
and Gynecology, Long Island College of Medicine, Dr. Stewart Schloss, and Miss
Frances I. Foster.
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FIG. 6. Curves of the effect of estrogen on finger volume in an ovariectomized
woman. rrop effect of estradiol dipropionate on March 6th; 2nd line, effect
on March 13th; 3rd line, on March 23rd; 4th line, April 17th; 5th line, May 1st;bottom line, on May 29th. See figure 8 for the graph summarizing this case.
The vertical white line in each curve indicates the conclusion of the injection of
estrogen. The sudden drop in the curve in the top line indicates the point where
the droplet was moved to the starting point for recording the rest of the response.
In the 4th line, the droplet was raised to the recording level. The first three
curves are the "plateau type" of dcrmovascular response, the last three, the
"flush type" (see text). It will be noted that there was mild exacerbation of
flushes on the last three curves attributable to uncertain conditions at home, or
to worry over uterine bleeding which was induced after the estrogen level was
decreased (see fig. 8). Time, minutes.
Fin. 7. Plethysmographic records of true menopausal flushes, uncomplicated
by injection of estrogen. Appreciable vasodilatation occurred. For tempera-
ture changes, see figure 10.
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with the type of estrogen used, and not with seasonal variations.
Data have been obtained from November throughout the winter
months and into June, but the trend of the dermovascular re-
sponses is roughly characteristic for each person, whether treat-
ment was commenced in the winter or in the spring.
The second type of response to estrogen is seen less frequently.
It is characterized by a slow increase in finger-volume to a maxi-
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FiG. 8. Summary of the dermovascular responses in one patient who experi-
enced satisfactory relief from menopausal flushes, but Still- resuires treatment
See figure 6.
mum, followed by partial subsidence to a plateau which is main-
tained for the period of observation. Such a response is shown
in the bottom curve of figure 6, and it is not unlike the responáe
The estrogens used have been liberally supplied by commercial concerns as
follows: estrone, Estrone Abbott, and Theelin, Parke, Davis & Co.: estradiol for
oral use, Progynon D-H Schering Corp., Ovocylin, Ciba; estriol, Estriol Ab-
bott; estradiol benzoate, Progynon-B, Schering Corp.; estradiol dipropionate,
Di-Ovocylin, Ciba.
a
is
 
M
o 
I 
lii
i 
I 
I 
I 
I 
I 
I 
O
LL
LV
LJ
4D
LJ
 
D
ec
em
be
r 
Je
fte
wy
 
Fe
br
ue
ry
 
Ap
.iI
 
M
ey
 
W
-S
/-M
 
5.
.9
fc
'/ 
Fm
. 9
. 
Su
m
m
ar
y o
f d
er
m
ov
as
cu
la
r re
sp
on
se
s i
n 
a 
pa
tie
nt
 w
ho
se
 f
lu
sh
es
 r
et
ur
n w
ith
 m
o
de
ra
te
 se
v
er
ity
 pr
io
r t
o 
re
tu
rn
in
g 
to
 th
e 
cl
in
ic
. 
DRM0VABCtrLAR ACTION OF ESTROGEN 17
of a true menopausal flush, two examples of which are shown in
figure 7. In the graphs (figs. 8 and 9), the occurrence of the
flush-type of response is indicated by the stippled areas above
the black bars in the row marked "volume-change." With
the exception of one of the subjects in whom this type of response
usually occurs, the flush-type of response has been observed
either very early in the course of treatment when the subject
was in a highly nervous state, or at later times, when some ex-
citing or disturbing factors are present. When it occurs, the
patient experiences uncomfortable sensations; she feels warm
over the neck, back, face and arms; she perspires and appears
flushed. With continued estrogen therapy, the plateau-type of
dermovascular response is usual.
Estrogen dosage and the derinovascular response. At the outset
of this work, three patients were transferred from the endocrine
clinic in the hospital where they had been receiving intensive
estrogen treatment. To our surprise, these patients never ex-
hibited a pronounced dermovascular response, while those who
were just commencing treatment showed considerable responsive-
ness to the hormone. It was apparent from the first, therefore,
that the amplitude of the response is not governed by the amount
of hormone injected, but rather by the condition of the subject
at the time of the injection.
The dosage of the several estrogens employed may not be
compared with each other, since there is not yet agreement on
the relative physiological potencies of these substances. With
each type of estrogen, however, responses have been obtained
to two or more levels of dosage. When all the cases were re-
viewed with this in mind, we failed to find correlation between
dose and response, even in the same subject. If, however, com-
parison is made of the effects of two or three dosages on patients
who are free of menopausal flushes, there are some instances which
suggest that the amplitude of the finger-volume change is af-
fected by the dose. This is shown in figures 8 and 9, where one
or two milligrams appear to give smaller responses than five
milligrams of estradiol-dipropionate. In another case,however,
there is clearly no demonstrable relationship between dose and
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effect, despite the fact that the subjective symptoms of the meno-
pause were well under control.
Duration of treatment and the response. There is no simple
statement to describe the effect which prolonged estrogen therapy
will invariably have on the dermovascular responses. Several
women have yielded small responses at the outset, while most
have given large reactions first. These tend to become pro-
gressively smaller as treatment continues. A few women have
given variable responses throughout most of the course of treat-
ment. it is evident from examination of all the records, however,
that the size of the response is in general proportional to the
severity and frequency of the flushes. As examples of this,
one sees in figure 9 that the incidence of flushes is usually ac-
companied by larger responses than those seen in figure 8, in
which case there was persistent relief from the flushes, and the
finger-volume changes were for the most part small.
Relation of menopausal flush to the dermovascular reaction.
In conclusion, comparison may be made of the chief character-
istics of the dermovascular reaction to estrogen and the skin
changes which occur during a menopausal flush. Several such
menopausal flushes, uncomplicated by the injection of estrogen,
have been observed from time to time. Some were obtained
while the subject was seated for the plethysmographic recording,
and a few were obtained while records of vaginal, face and leg
temperatures were being recorded.
The menopausal flush differs from the plateau-type of response
described above in two respects: it attains a maximum very
quickly (see fig. 7), it usually subsides rather quickly, and it is
usually of ten to fifteen minutes' duration. This last feature
is interesting, since the patient notices,—and minds,—the flush
most in the early, rising phase. In contrast to this, the plateau-
type of dermovascular response is rarely associated with an
unpleasant sensation of warmth in women. This was also found
to be so in the earlier study on men.
There is a further difference between the dermovascular re-
sponse of the plateau-type and the menopausal flush. In the
former, there is no measureable increase in skin temperature,
DERMOVASCULAR ACTION OF ESTROGEN 19
as noted in the earlier study (Reynolds and Foster, 1939). In
the flush, there is an appreciable increase in skin temperature,
as shown in figure 10 where temperature measurements during
such a response are recorded. Although the flush in this case,
and in others observed in the same patient, was associated with
a rise in internal (vaginal) temperature, this was not found to
be the case in two other patients. The relationship of surface
to internal temperatures must await more extended studies.
EFFECT OP MENOPAUSAL FLUSH ON BOOr TEMPERATURES
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Fio. 10. Summary of temperature data of vaginal, face and leg temperatures
on a woman in natural menopause who experienced a flush at the time of observa-
tion. Note the increase in skin temperature, but the lack of it in the dermo-
vascular response shown in figure 5. See text for the basis of this difference
between the flush and the dermovasoular effect of estrogen.
The significance of the difference in temperature character-
istics of the two vascular responses may be mentioned in closing.
The fact that vasodilatation of the finger takes place without a
concomitant rise of skin temperature suggests that the change
involves the blood vessels lying beyond the arterioles, and that
there is little or no change in the rate of blood flow through the
finger. In the menopausal flush, however, where there is both
dilatation and an increase in skin temperature, there is an ap-
preciable increase in the rate of blood flow through the skin,
clearly as the result of arteriolar dilatation in the affected areas.
There is in the menopausal flush, accordingly, intermediation
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of nervous factors to bring about a diminution of arteriolar tone,
as there clearly is in the sweating which accompanies this re-
sponse, also (cf. Reynolds, 1939). The dermovascular response
to estrogen, on the contrary, involves vessels which are not
modified by nervous activity, and it would appear that the
consequences of estrogen therapy in the menopause include an
alteration in the condition of the smallest vessels of the skin.
This is attested by the development of a "tolerance" to estrogen
as relief is afforded, so far as the dermovascular effects are con-
cerned. Further experiments on the quantitative aspects of the
tache reactions of the skin wifi have to establish this new func-
tional state of the minute vessels. Moreover, further experi-
ments wifi be necessary to demonstrate the extent to which
estrogen may be effective in relieving menopausal flushes through
alteration in the relation of the skin and internal temperatures
by virtue of the derinovascular action which estrogen clearly has.
SUMMARY
1. A review is given of the experiments reported in earlier
papers on the vasodilating effect of estrogen on the capifiaries
and venules in the skin of the ear of the rabbit and in the human
male. The increase in finger-volume involves the capillaries
and venules, and does not alter appreciably the rate of blood
flow through the skin. The response is in the same direction,
though less than that seen in the genital tract following injec-
tion of estrogen.
2. A summary is made of work now in progress on the dermo-
vascular effect of estrogen in women in menopause. it is shown
that two types of response may occur, one, a sustained plateau,
the other, a flush-type of response. The latter is observed in
women who are nervous before treatment, or during a period of
return of symptoms in the course of treatment. The dermo-
vascular effect of estrogen appears to become less marked as relief
from vasomotor disturbances taken place.
3. Comparison is made of the menopausal flush and the dermo-
vascular reaction to estrogen. it is shown that in both vaso-
dilatation occurs, but that in the menopausal flush the effect is
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in part due to arteriolar dilatation, and in the estrogen-response,
the smallest vessels beyond the arterioles are concerned. The
former involves intermediation of nervous activity (inhibition
of arteriolar tone), the latter, appears to be a direct effect of the
hormone on tissues in or about the blood vessels.
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DISCUSSION
DR. JAMES B. HAMILTON, New Haven: I wish to compliment Dr. Reynolds on
the work he has been doing. We have been studying by use of the spectropho-
tometer, the effect of sex hormones on pigments in the skin of castrate men—work
done in conjunction with Dr. Edward Edwards of the Harvard Medical School
and Dr. S. Q. Duntley of Massachusets Institute of Technology. Following
administration of hormone substance we have seen responses somewhat similar
in type to those found by Dr. Reynolds. So that what he has described applies
also in the male and to some extent, unpredictable at present, is simulated by
male hormone substances.
DR. HERMAN SHARLIT, New York City: This presentation, it would appear to
me, has a very direct application to dermatologists, particularly with respect
to public health measures.
We are all aware that the estrogenic hormone is absorbed through the skin,
and that cosmetic manufacturers, for quite a few years now, have been putting
estrogenic hormones in creams.
The attitude of the medical profession with respect to this procedure has
been to decide whether this was safe from the point of view of the larger prob-
lem of carcinogenesis. From this type of experimentation, it would appear
definitely that estrogen could very well form a basic drug in the pharmacological
sense, since it would influence the capillary size of the skin. In this respect,
such a product, while in itself not very important, would be of some value in
determining to what extent it would be permissible to introduce its distribution
as a cosmetic. Time alone will tell what such a cosmetic can do, and how safely
it may be used.
Dn. TEEODORE CORNBLRRT, Chicago: I am interested in the relationship
between estrogen and the behavior of the blood vessels of the skin under its
influence. They can readily be studied in Rosacea. Rosacea appears usually
during the age period when the follicular hormone may be expected to wane.
Oily extracts of ovary, such as the product Sistomensin (Ciba) contract telan-
giectases and blanch the suffused areas of rosacea in many cases. The synthetic
estrogens are useful for this purpose, but I think not as rapidly as the extract of
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whole ovary. The most rapid and complete results occurred in women towards
and beyond the menopause. Younger women did not respond favorably. A few
men improved partially after prolonged therapy. The degree of their changes
lay between that in the menopausal and the young women. In a forthcoming
publication I shall discuss measures other than the administration of estrogen,
which are more effective in men. Just how permanent these results will be I
cannot, as yet, say, although I have been following some of these patients for
several years. In spite of that, I am still rather conservative in my judgment.
In several cases, it seems apparent that the improvement is permanent. I think
that estrogen unquestionably has a potent action on the blood vessels of the skin
and influences, among other things, their caliber. These oily extracts of ovary
or estrogens do not influence the papules or popular pustules in patients with
Acne rosacea. They act only on the blood vessel dilatations.
Dn SAMUEL R. M. REYNOLDS, Brooklyn, N. Y.: We have used Perandren
(male sex hormone) in some women and have obtained the same type of results
as Doctor Hamilton. I did not have time to go into the literature, and do not
profess to be familiar with the literature on the relationship between the sex
hormones and the clinical applications as far as dermatology is concerned.
Dr. Sprunt of Duke University has carried out observations showing the ab-
sorbability of various types of matter injected into the skin, as affected by the
hormonal state of the animal, with particular regard to the sex hormones.
I did not go into the mechanism of the vaso-dilatation resulting from injection
of estrogen. In the rabbit this vaso-dilatation can be inhibited by the previous
injection of atropin.
It would appear on this basis that the vaso-dilatation is associated with an
increase in the amount of acetyicholine present in the tissues. In order to test
this, we have made determinations on the acetyicholine concentration in various
tissues. We have not been able to find measurable amounts of acetyicholine in
the skin of the rabbit, the cat or the rat, but we could obtain measurable quan-
tities after the injection, in the nasal mucosa.
We have also shown that this same type of response is associated with the
hyperemia which is found in uterine tissues. We can recover very appreciable
quantities of acetyicholine after the injection.
In closing, I should like to say a word about carcinogenesis. I am not im-
pressed with this as a danger in the long use of estrogenic substances in the treat-
ment of menopause. Only one aspect of a patient's history would make me
question the likelihood of such a danger, and that is whether any of the patient's
relatives have had carcinoma. I know no human case in the literature in which
carcinoma has been induced specifically by any of the sex hormones. One can
induce carcinogenesis only by the injection over a relatively long period of time,
in high dosage, in animals already highly susceptible to cancer. This has been
observed only in mice and rats.
